Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.9060
-0.0414 (-4.37%)
Mar 6, 2026, 4:00 PM EST - Market closed

Biodexa Pharmaceuticals Revenue

Biodexa Pharmaceuticals had revenue of 13.50K GBP in the half year ending June 30, 2025.

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
759.94K USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023381.00K-318.00K-45.49%
Dec 31, 2022699.00K654.62K1,475.10%
Feb 28, 202244.38K-533.62K-92.32%
Dec 31, 2021578.00K-4.02M-87.43%
Feb 28, 20214.60M4.25M1,240.44%
Dec 31, 2020343.00K-331.00K-49.11%
Dec 31, 2019674.00K-1.26M-65.22%
Dec 31, 20181.94M949.00K95.96%
Dec 31, 2017989.00K-334.00K-25.25%
Dec 31, 20161.32M-52.00K-3.78%
Dec 31, 20151.38M1.22M775.80%
Dec 31, 2014157.00K10.00K6.80%
Dec 31, 2013147.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ensysce Biosciences4.49M
Onconetix1.22M
Lyra Therapeutics600.00K
PMGC Holdings285.95K
Aditxt5.95K
Virax Biolabs Group2.99K
Revenue Rankings